Clinical Trials Logo

Clinical Trial Summary

This project is a single blind cluster randomized controlled trial with a purpose of assessing the effectiveness of a comprehensive tertiary interventions (before pregnancy, during pregnancy and after delivery) on the incidence and the clinical outcomes of birth defects in a preparing-for-pregancy population in Shanghai. The preconception intervention is focused on identifying individuals whose red blood cell folate level is below recommended level for preventing neural tube defects (400ng/ml) or with elevated homocysteine level (over th 80th percentiles, 6.8 µmol/L) , and modifying their folate deficiency status to normal before pregnancy.


Clinical Trial Description

According to World health Organization (WHO), approximately 3.2 million children are born with birth defect(s) worldwide and the incidence of birth defects in China is 5.6%. Birth defects are the main cause of fetal death, infant mortality and morbidity, and long-term disability. Congenital heart defects, oral clefts, hydrocephalus, neural tube defects and mental retardation are most common birth defects in China. Though the etiology of birth defects is still unknow, many studies indicated that maternal key nutrition factors, especially maternal folic acid status, during periconception played an important role in organogenesis, reducing the incidence of neural tube defects, congenital heart diseases and some other birth defects. Our project is a single-blind, cluster randomized controlled trial that aim at evaluating whether hospital-based tertiary intervention approaches reduce the incidence of birth defects (compound primary outcomes, including neural tube defects, congenital heart defects, cleft lips and palates, hydrocephalus, alimentary tract malformations or urological deformities) that identified at middle of gestation via ultrasound or clinical observation at birth. Every couple attending premarital check or preconception physical examination from Minhang and Songjiang district in Shanghai will be recruited. Recruited couples are to draw blood samples and invite to complete questionnaires that collecting informations on diet supplementation. Comprehensive interventions before conception are based on serum folate, red blood cell folate, homocysteine, vitamin B12 and fasting glycemic and lipids profiles. Single nucleotide polymorphisms related to folate and homocysteine matalism pathway will be genotyped in participants with sufficient intake of folic acid but unknown deficiency of the nutrients. Venous blood of pregnant women and questionnaires about the supplementation of key nutrients at the first antenatal visit are also obtained. NT examination, Down's screening, and ultrasound examination results are collected during the second trimester (15-24 gestational week), then routine prenatal genetic counseling, assessment, and diagnosis are provided according to the local policy to those pregnant women with positive screen results indicating high risk of fatal birth defects. Newborns with above mentioned birth defects are provided green channel to clinical specialty team for further diagnosis, surgical correction and rehabilitation guidance. Clinical follow up will be conducted till 6-month old for the prognosis of treatment. The current project will provide evidence on the necessity and effectiveness of preconception intervention focusing on sufficient folate nutrition levels in prevention of birth defects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03725878
Study type Interventional
Source Children's Hospital of Fudan University
Contact
Status Active, not recruiting
Phase N/A
Start date October 31, 2018
Completion date September 10, 2024

See also
  Status Clinical Trial Phase
Completed NCT00340977 - Svangerskap, Arv, Og Miljo (Pregnancy, Heredity and Environment)
Completed NCT00766571 - Clinical and Genetic Studies of VACTERL Association
Completed NCT00015561 - Pesticides--Health Fertility and Reproductive Risk N/A
Completed NCT02391610 - The China-Anhui Birth Cohort Study (C-ABCS) N/A
Completed NCT02055248 - Study on Moebius Syndrome and Congenital Facial Weakness Disorders
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)
Active, not recruiting NCT01097720 - Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine N/A
Completed NCT05318222 - Genetic Inclusion by Virtual Evaluation N/A
Completed NCT01294345 - Personalized Genomic Research
Terminated NCT00579150 - Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy Phase 4
Terminated NCT00114712 - The Ribavirin Pregnancy Registry
Active, not recruiting NCT06048276 - Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study
Terminated NCT00232713 - Uterine Fibroid Pregnancy Registry
Completed NCT00345475 - UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry) Phase 4
Completed NCT00340366 - Influence of Genetics on Vitamin Metabolism in Pregnant Women N/A
Recruiting NCT04182503 - Environmental Factors and Embryonic Development Project
Completed NCT00317564 - Betaseron Pregnancy Registry